News
Refinitiv
www.reuters.com
Mihael Polymeropoulos. Dr. Mihael H. Polymeropoulos, M.D., is President, Chief Executive Officer, Director of the Company. Prior to joining Vanda, Dr.
Communication Crucial to Developing Non-Preagreed Endpoints ...
www.fdanews.com
When asked the key to Vanda's success, CEO Mihael Polymeropoulos pointed to good research and constant communication with the agency ...
FDA panel backs sleep pattern drug for blind - PMLiVEwww.pmlive.com/pharma.../fda_panel_backs_sleep_pattern_drug_for_blind_
www.pmlive.com
... with a 24-hour world," commented Vanda chief executive Mihael Polymeropoulos during the company's third-quarter results call last week.
Novartis and Vanda Pharma's Schizophrenia Treatment May Be DOA - CBS...
www.cbsnews.com
Mar 08, · Even a licensing deal with Novartis (NVS), however, ... In my opinion, chief executive Mihael Polymeropoulos has not only ignored the adage,
sorted by relevance / date